Archivel Farma joins the Advanced and Emerging Therapies Network of Catalonia, strengthening its involvement in the collaborative ecosystem supporting advanced therapies. As part of its activities in this field, the company is developing a lentiviral vector platform at R&D level, with the objective of facilitating its future translation to GMP manufacturing.
